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A B S T R A C T
Background: Intracerebral infusion of anticonvulsant agent secreting cells has proven to raise the
threshold for seizure generation in epileptogenic areas. Median ganglionic eminence (MGE) is the main
embryonic region where future GABAergic cells originate. Here we report the results of intraamygdaline
grafting of MGE cells versus ﬁbroblasts in a piriform cortex kindling model of epilepsy in the rat.
Material andmethods: Rats were implanted with an electrode in the left piriform cortex and subjected to
infusion at the left basolateral amygdala of cells obtained from the MGE of embryos or ﬁbroblasts. Some
of the donor cells were obtained from transgenic rats expressing the green ﬂuorescent protein (GFP).
Seizure and neurologic behavior were recorded, and inmunohistochemical and ultrastructural studies
were carried out.
Results: Cells obtained from the embryonic MGE elevated both the afterdischarge and the seizure
threshold progressively, being signiﬁcant 3 weeks after their injection. On the contrary, ﬁbroblasts
injected into the amygdala raised the seizure thresholds the ﬁrst week, the effect weaning during the
following weeks. Fibroblasts and MGE cells were shown at the injected amygdala. No behavioral side
effects were recorded in either experimental group.
Conclusion: MGE cells implanted at the amygdala may control the focal component of temporolimbic
seizures. This effect may be mediated by local release of GABA.
 2010 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Resective surgery for the treatment of drug-resistant mesial
temporolimbic epilepsy may be very effective, with an overall 66%
complete seizure control.1 However, resection of potentially
functional structures such as the anterior temporal lobe, amygdala
or hippocampus could lead to loss of function.
Alternatives to resective surgical treatment of temporal epilepsy
may take the approachof restorative surgery. Somecasesof epilepsyAbbreviations: GABA, g-aminobutyric acid; MGE, median ganglionic eminence;
GFP, green ﬂuorescent protein; ADT, afterdischarge threshold; GST, generalized
seizure threshold; ST, seizure threshold; SS, seizure severity; DMEM, Dulbecco’s
modiﬁed Eagle’s medium; PBS, phosphate buffered saline; TuJ1, class III b-tubulin;
NeuN, neuronal nuclei neuron-speciﬁc nuclear protein; IPSC, inhibitory postsyn-
aptic current.
* Corresponding author at: Servicio de Neurocirugı´a and Instituto de Neuro-
ciencias, Hospital Clı´nico San Carlos, Calle ProfesorMartı´n Lagos, s/n. 28040Madrid,
Spain. Tel.: +34 609707525; fax: +34 913 303 469.
E-mail addresses: ugomez@cipf.es (U. Go´mez-Pinedo), Juan.A.Barcia@uv.es
(J.A. Barcia).
1059-1311/$ – see front matter  2010 British Epilepsy Association. Published by Else
doi:10.1016/j.seizure.2010.06.001maybeviewedas a loss ofGABAergic function, therefore continuous
local delivery of GABA should permanently correct this.
We have previously shown that local delivery of GABA to the
amygdala increases both the afterdischarge and the seizure
thresholds of the amygdala kindled rats.2 Other researchers have
used genetically engineered cells that released GABA to impair the
development of kindling.3
It has been shown that precursor cells form the embryonic
median ganglionic eminence (MGE), an embryonic source of
GABAergic cells, when injected into adult mammalian brain tissue,
are able to disperse and differentiate into neurons inmultiple adult
brain regions. One-third of these cellswere stainedwith antibodies
against GABA.4 In a subsequent study, these cells were shown to
migrate throughout the brain when injected in postnatal animals,
express GABAergic phenotype and establish inhibitory synaptic
connections with host neurons.5
The purpose of this study was to determine the anticonvulsant
effect of the local injection of MGE cells in the amygdala in a
temporolimbic kindling model in the rat. As controls, we injected
ﬁbroblasts.vier Ltd. All rights reserved.
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2.1. Animals
For the kindling experiments, we used adult male Wistar
rats, bred under standard colony conditions in the facilities of
the Research Centre of the University General Hospital in
Valencia (Spain). Fibroblasts and embryonic median ganglionic
eminence cells (MGE) were obtained either from wild type or
from transgenic rats expressing the green ﬂuorescent protein
(GFP). The experimental protocols were approved by the
corresponding institutional animal care committee, in compli-
ance with current European directives for animal experimenta-
tion (86/609/ECC) and with those set by the Valencian
Community Government.
2.2. Kindling procedure
Animals weighing 270–310 g were stereotactically implanted
with a bipolar electrode at the left pyriform cortex, and a cannula
directed to the left basolateral amygdala. Animals were anaes-
thetised with an intraperitoneal (i.p.) injection of a mixture of
ketamine (100 mg/kg), diazepam (8 mg/kg) and atropine sulphate
(0.4 mg/kg). The electrode consisted of a twisted pair of 0.2 mm
diameter Teﬂon-coated stainless steel wires (Advent Research
Materials, Suffolk, England), the tips of which were exposed by
0.2 mm and separated by 0.5 mm, and then placed at the following
coordinates: 0.8 mm posterior, 4.9 mm left, and 8.8 mm ventral
from the bregma.6 The cannula was made of stainless steel
(0.7 mm outer diameter, 15 mm long), and an appropriate stylet
was put in place. The tip of the cannula was stereotactically
implanted at a distance 5 mm from the basolateral amygdala, at
the following coordinates: 2.2 mm posterior, 4.8 mm left, and
3.5 mm ventral from the bregma.6 Four symmetrical, chlorinated,
silver recording electrodes were implanted into the epidural space
(two frontal and two occipital). In addition, an indifferent electrode
was placed under the skin of the neck. All electrodes were
connected to a 7-pin miniature connector. The cannula, electrodes
and connector were ﬁxed to the skull vault with dental acrylic
cement, and the skinwas closedwith silk suture at both ends of the
incision. After surgery, animals were individually caged.
A standard kindling procedure commenced 10 days after
surgery, which involved daily stimulation with a 1-s train of 50 Hz
square wave pulses (1 ms duration and 500mA amplitude), using a
Grass S88 stimulator, until more than three consecutive stage 5
seizures7 were provoked. At this point, the animal was considered
fully kindled. The afterdischarge threshold (ADT) and seizure
threshold (ST) were determined 3 days before implantation. This
was done using a stepwise ascent method,8 consisting of
stimulation with a series of 1-s train of 50 Hz square wave, in
pulses lasting 1 ms, separated by 1 min intervals. Current intensity
began at an amplitude of 7mA andwas increased gradually, by 20%
each step, to 500mA, or until a behavioral seizure occurred. The
amplitude reached when a seizure was produced was considered
to be the seizure threshold (ST). Similarly, the lowest amplitude to
elicit an afterdischarge of at least 5 s was considered to be the
afterdischarge threshold (ADT).
Thresholds were ﬁrst measured on Tuesdays, 3 days before
implantation, and this procedure was repeated over the following
2 days, and the mean of the three determinations was considered
as the control threshold value.9
2.3. Implantation of cells
Once the animals were fully kindled, basal seizure readings
were taken the 3 days just before implantation. The animals wereanaesthetised once more with the same intraperitoneal injection
mixture as previously described, in order to be implanted with
either ﬁbroblasts (n = 8) or cells from the MGE (n = 8).
MGE cells were obtained from embryonic day 14.5 embryos of
homozygote transgenic rats ([Wistar-TgN(CAG-GFP)184ys]) with
constitutive expression of green ﬂuorescent protein (eGFP) (Rat
Resource and Research Center, University of Missouri, USA).
Parents were paired on Thursdays 2 weeks before implantation.
We used one mother for each three implants (6–8 fetuses per
mother, about 2.5 fetuses per implant).
The lateral ventricular wall was dissected under magnifying
loupes. The tissue from the area near the sulcus between MGE and
the lateral ganglionic eminence was discarded in order to avoid
contamination. The explant was mechanically dissociated,
digested with DNase I and centrifuged, and a suspension of about
100,000 cells per ml of DMEM was prepared. The ﬂuorescence of
such cells was checked with a ﬂuorescencemicroscope prior to the
injection. 1ml of such suspension was injected to 8 fully kindled
rats with a Hamilton syringe through the 21G cannula at the left
basolateral amygdala, at the coordinates 2 mm posterior, 4.8 mm
left and 8.5 mm ventral from Bregma.6
Fibroblasts were obtained from adult rat muscle. The muscle
was dissected and triturated with collagenase II (4 mg/ml) in PBS
(phosphate buffered saline), obtaining a cell suspensionwhichwas
adjusted to a cell density of 1  105 viable cells/cm2 and seeded in
plates. Fibroblasts were cultured asmonolayers in DMEM, 10% PBS,
streptomycin + penicillin (100 mg/ml) and amphotericin (100 mg/
ml) (Gibco; http://www.invitrogen.com). Cultures were incubated
in a humidiﬁed atmospherewith 5% CO2 in air at 37 8C. Cell transfer
was performed by enzymatic dissociation with 0.25% trypsin in
PBS (Gibco). Counting was made with a Bu¨rker chamber, and 1ml
containing 100,000 cells was injected through the cannula.
MGE cells and ﬁbroblasts showed the appropriate in vitro
markers Vimentin for ﬁbroblasts and Tuj1 (class III b-tubulin) and
NeuN (Neuronal Nuclei) for MGE cells.
2.4. Experiments
The anticonvulsant effect determination began on the third day
after implantation. It was determined at the same time each day
over a 5-weekday period (Monday to Friday) during 3 weeks. This
was done through stimulation of the left pyriform cortex with the
same parameters as in the kindling process in order to elicit a
seizure (1-s train of 50 Hz square wave pulses, 1 ms duration and
500 mA amplitude). The parameters measured were ADT, ST and
Racine’s seizure stage.7 The ADT and the ST were measured using
the stepwise ascent method described in the previous section.
Neurological side effects were tested immediately prior to
stimulation by means of the following scales of ataxia and
sedation:10
Ataxia: 0 = absent, 1 = slight ataxia in hind legs, 2 = more
pronounced ataxia with dragging of hind legs, 3 = further increase
of ataxia and more pronounced dragging of hind legs, 4 = marked
ataxia and loss of balance during forward locomotion, 5 = consid-
erably marked ataxia with frequent loss of balance, 6 = permanent
loss of righting reﬂex; sedation: 0 = absent, 1 = slightly reduced
forward locomotion, 2 = reduced locomotion with rest periods
between periods of locomotion, 3 = reduced locomotionwithmore
frequent rest periods, 4 = no forward locomotion and the animal
sits still with closed eyes.
2.5. Immunohistochemical study
Once the experiments were completed, animals were sacriﬁced
with an intraperitoneal injection of pentobarbital. The appropriate
position of the electrode at the medial pyriform cortex was
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removal of the electrode.
Animals were perfused with 4% paraformaldehyde, and after
decapitation, their skulls were opened and the brains extracted.
Thesewere immersed into 0.1 M PBS at pH 7.4. The brains were cut
in 100 mm thick coronal sections using a vibratome (Leica VT
1000S) and were serially collected in PBS.
GABA expressing cells were detected with a rabbit antibody
against GABA at a dilution of 1:2500 (Sigma, St. Louis, MO). This
primary antibody was detected with a Cy5-conjugated AfﬁniPure
goat anti-rabbit secondary antibody at a dilution of 1:200 (Jackson
InmunoResearch). For NeuN we used Chemicon mouse monoclo-
nal IgG MAB377, at a concentration 1:100. For Tuj1 we used
Covance PRB 435P, rabbit polyclonal IgG, at a concentration 1:250.
For Vimentin, we used in culture mouse antivimentin DakoCyto-
mation, concentration 1:200 and in tissue mouse monoclonal
antivimentin clone V9, Sigma–Aldrich, concentration 1:200.
GFP+ cells were detected using a Leica FW 4000 ﬂuorescence
microscope, using GFP ﬁlters, with a maximum excitation of
480 nm and maximum emission of 507 nm. Images were digitally
captured for analysis with a DFC480 digital camera and IM500/
FW4000 image manager software (Leica, Cambridge, UK) on a
DM6000B microscope (Leica, Wetzlar, Germany).
2.6. Statistical analysis
Wilcoxon’s signed-rank test for paired replicates11 was used to
calculate the signiﬁcance of individual differences between seizure
and toxicity parameters after the cell implantation and controls of
the same animals before cell implantation. Statistical signiﬁcance
was considered when p < 0.0166, since we had to apply aFig. 1. Box plot of the median (plus quartiles and extremes) weekly ADT and GST in ani
becoming signiﬁcant at week 3 (p = 0.008) according to Wilcoxon’s signed-rank test w
Fig. 2. GFP+ cells, many of them GABA+, at the injection site, 5Bonferroni correction. This correction was necessary because
repeated comparisons were made three times in each group of
animals. Median values of each week were compared to baseline
values. Data were also analyzed with ANOVA for repeated
measures (general linear model) and they conﬁrmed the major
ﬁndings, but this was not taken into account because the different
measures contravened the conditions of normal distribution and
similarity of variances.
Values are shown as median (range), unless otherwise
speciﬁed.
3. Results
Results are summarized in Table 1.
3.1. Results of MGE cells implantation
3.1.1. Results on epileptic activity
Animals which received an implant of MGE cells showed a
delayed but progressive improvement in the seizure parameters
over time (Fig. 1). ADT and GST did not show any signiﬁcant
difference as compared with pre-implant controls on weeks 1 and
2. On week 3 both thresholds raised signiﬁcantly (p = 0.008).
Seizure intensity was class 5 whenever it was elicited. No signs of
neurological side effects were recorded in any of the animals.
3.1.2. Survival and integration of implanted MGE cells
GFP+ cells were observed by immunoﬂuorescence at the
injection site in the left amygdala, many of them coexpressing
GABA as revealed by anti-GABA immunostaining (Fig. 2), but were
also seen migrating towards other brain areas, speciﬁcally, themals implanted with MGE cells. There is a progressive increase of both thresholds,
ith Bonferroni correction.
days post-implant (left: GFP, right GABA, middle fusion).
Table 1
Effect on the seizure parameters recorded before (pre-implantation), and the 3 weeks after (days 3–7, 10–14 and 17–21) intra-amygdalar implantation of MGE cells or ﬁbroblasts. Wilcoxon’s signed-rank test with Bonferroni
correctionwas used to calculate the signiﬁcance of individual differences betweenmedian values of seizure thresholds of the 3weeks post-implantation and the pre-implantation threshold. After implantation ofMGE cells increases
on ADT andGSTwere only signiﬁcant comparedwith pre-implant controls onweek 3 (p=0.008). Animalswhich received an implant of ﬁbroblasts showed a signiﬁcant improvement in GST the ﬁrstweek (p=0.008), but a progressive
worsening was noticed in the following weeks. Each parameter is expressed as median (minimum, maximum). ADT, afterdischarge threshold; ADD, afterdischarge duration; GST, generalized seizure threshold; GSD, generalized
seizure duration; SS, seizure severity (Racine’s score). Signiﬁcant results are marked in red.
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Fig. 3. GFP+ cells, many of which immunostain positively for GABA, are seen at the cortex 3 days post-implant (left: GFP, right: GABA, middle: fusion).
Fig. 4. (Detail) GFP+ cells showing morphologic features of interneurons seen at the
injection site (amygdala), 4 days after injection.
Fig. 5. Cells at the cannula site expressing immature neuron markers (TuJ).
Migrating neurons can be seen around the cannula site.
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Many of these cells showed morphological features of interneur-
ons (Fig. 4) and expressed Tuj-1 (Fig. 5) and NeuN (neuroﬁlament)
markers.
3.2. Results of ﬁbroblasts implantation
3.2.1. Results on epileptic activity
Animals which received an implant of ﬁbroblasts showed an
immediate improvement in the seizure parameters, but a
progressive worsening was noticed in the following weeksFig. 6. Box plot of the median (plus quartiles and extremes) weekly ADT and GST in anim
week 1 after implantation, which decays duringweeks 2 and 3. GST increased signiﬁcantl
correction.(Fig. 6). Unlike animals with MGE cell grafts, GST recorded after
ﬁbroblast implantation showed an immediate increase, with some
animals showing no seizures with stimuli up to 500 mA during the
ﬁrst week. This was reﬂected in a signiﬁcant increase of GST during
the ﬁrst week. However, this effect decreased on the second week,
only the GST being slightly above the controls, and disappeared on
the third week.
3.2.2. Survival of implanted ﬁbroblasts
Histological and immunohistochemical study of animals
implanted with ﬁbroblasts showed GFP+ and vimentin+ cells atals implanted with ﬁbroblasts. There is an immediate increase of both thresholds at
y the ﬁrst week (p = 0.008) according toWilcoxon’s signed-rank test with Bonferroni
J.M. Gallego et al. / Seizure 19 (2010) 461–466466the point of implantation in the amygdala, at the pyriform cortex
around the electrode and at the ventricular walls.
4. Discussion
Grafting of inhibitory interneurons may be a promising
alternative to surgically control epilepsy. Our results show the
potential antiepileptic effect of the injection of GABAergic cell
precursors obtained from the embryonic MGE. Our data show that
such transplanted cells are able to increase the current intensity
threshold to evoke both local afterdischarges and seizure
generalization in an epilepsy model, showing graft survival and
function in a pathologic environment. These data support the
results obtained by other researchers using genetically modiﬁed
GABA releasing cells,3,12 which have shown their ability to
decrease the epileptogenic process of kindling.
Previous studies4 have shown that precursor cells obtained
from the embryonic MGE and implanted into the brain of adult
micemigrate up to 1.5 mm from the graft site and differentiate into
neurons expressing GABA. Another study5 has shown that these
cells, when implanted into neonatal brain, are able to functionally
integrate into local circuits, establishing afferent and efferent
synaptic contacts and inducing spontaneous inhibitory postsyn-
aptic currents (IPSC’s) onto the host pyramidal neurons, which
show a greater inhibitory activity than the contralateral controls.
These cells showmorphologic and inmmunohistochemical signs of
maturation between 3 and 7 days after transplantation. Between
14 and 21 days after transplantation, the morphologic character-
istics of mature cell becomemore evident. Moreover, these cells do
not show evidence of extensivemigration 3 days after grafting. The
number of surviving cells stabilizes after 30 days.
These features explain the progressive appearance of antiepi-
leptic properties 2 weeks after implantation. MGE cells implanted
onto neonatal brain in mice are not active until the fourth week,
which coincides with the time required to observe cells with
maturemorphology.5 The difference in species and in the age of the
host may account for the difference in the time to maturation.
According to the previously cited studies, the establishment of
functional inhibitory synapses may explain the antiepileptic effect
of the implanted cells. GABA bioavailability at the epileptogenic
area may also account for the antiepileptic effect, as we have
previously shown with local infusion of GABA using osmotic
pumps.2 Moreover, the effect of GABA infusion is also raising both
ADT and GST, without any effect on the seizure severity once it has
been triggered. GABA activity at the grafted site was conﬁrmed by
immunohistochemistry, since GFP+ MGE cells at the injection site
at the amygdala were also GABA positive as revealed by anti-GABA
immunostaining.
On the contrary, ﬁbroblasts are very active raising ST
immediately after transplantation, even to the point of complete
seizure suppression. This effect is transient, decaying over the
followingweeks. This timeline, opposite toMGE cells, account for a
direct effect of ﬁbroblasts at the epileptogenic area which cannot
be explained solely by a mechanic effect of the implant, since in
that case the implant of MGE would have shown a similar effect.
Fibroblasts may have either provoked a local inﬂammatory
reaction, not visible at our histological analysis, or they may
release an unidentiﬁed anticonvulsant factor. Other studies have
used genetically engineered ﬁbroblasts overexpressing adenosine,
and they proved to be an effective anticonvulsant agent when
injected locally.13 Thus, the release of adenosine or other
substances cannot be ruled out. Another possible explanation isa migration of the ﬁbroblasts to the electrode tip during the ﬁrst
week, with a possible insulating effect, which could be later
overcome by the repeated stimulation or by cell death.
ADT and GSTwere determined once per day at 5 days per week.
This may raise the concern about a possible increase of seizure
thresholds because of accumulation of endogenous anticonvulsant
mechanisms because of too frequent threshold determination.
However, we have followed this protocol in other studies and have
not recorded a signiﬁcant increase in ADT or GST.2,14–15
Further, the differences in the anticonvulsant effect of the two
cell types could be due to their different origin. Donor cells were
obtained fromWistar rats, but in allogenic transplants, even in the
central nervous system, an immune rejection response is possible.
This rejection would be expected to be smaller in cells of
embryonic origin than in adult cells. Thus, immune mechanisms
cannot be ruled out to explain the anticonvulsant effect of
ﬁbroblasts in the ﬁrst week and the later washout of this effect.
We conclude that anticonvulsant effect of GABAergic cell
implants deserves further study to establish its mechanism of
action, and more speciﬁcally, its possible synaptic integration in
the local circuitry. Studies in other models of epilepsy may also
elucidate the potential clinical role of this approach.
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